C1 Inhibitor (Human)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C1 Inhibitor (Human), covering 2018-12-31 to 2018-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) [Phase 3]